View
214
Download
0
Category
Tags:
Preview:
Citation preview
Getting Engaged: OC15 Closing Session
Cal CollinsCEO, OpenClinica
1
©
#OC15Europe
Amsterdam Canal Cruise
2
©
#OC15Europe
The ‘Which’ Problem
Which patients are
[eligible for my clinical trial]?
3
- Leonard D’Avolio, Harvard Medical School
©
#OC15Europe
The ‘Which’ Problem
Which patients are
[likely to benefit from this drug]?
4
©
#OC15Europe
The ‘Which’ Problem
Which patients are
[likely to benefit from this device]?
5
©
#OC15Europe
The ‘Which’ Problem
Which patients are
[able to manage their chronic condition]?
6
©
#OC15Europe
The ‘Which’ Problem
Which patients are
[able to access needed care]?
7
©
#OC15Europe
The ‘Which’ Problem
Which sites are
[likely to recruit patients to my trial]?
8
©
#OC15Europe
The ‘Which’ Problem
Which intervention is[most cost effective]?
9
©
#OC15Europe
The ‘Which’ Problem
Which doctors are
[likely to prescribe this drug]?
10
©
#OC15Europe
The ‘Which’ Problem Pharma, government, and healthcare are grappling with
what really provides value, how to evaluate/measure it
Better answers require better solutions that: Enable more cost-effective randomized trials Advance translational medicine Better incorporate “-omics” science into clinical research
and practice Get more and higher quality real-world ‘big data’ Engage patients as first class stakeholders in research
11
©
#OC15Europe
‘Which’ Solution? Our community is using OpenClinica as part of the
solution, often by integrating with other powerful tools or augmented with custom built extensions.
The difficulty of meaningful, timely engagement with study participants is a large obstacle to successful research. After all, there are no trials without these valued volunteers.
12
©
#OC15Europe
It’s 2015! 90% of adults have smartphones, 81% text, and 63%
use their phone to go online (Pew). Even older age groups are adopting smartphones at a rapid pace.
13
©
#OC15Europe
Get Engaged Technology revolutions happen by democratizing and
commoditizing information, through automation and scaling with low-to-zero marginal costs.
Everyone (almost) carries a network-connected supercomputer around with them 90%+ of their waking lives
14
©
#OC15Europe 15
Designing Research Closer to the Participant
©
#OC15Europe
The Best of Both Worlds
Can we…
Combine the rigor and exactness of RCTs with a big data approaches that yields richer answers about how the real world works,
Move at Internet speed; save money and increase the pace of research,
While ensuring patient safety, dignity, and privacy are protected better than ever before?
16
An approximate answer to the right problem is worth a good deal more than an exact answer to an approximate problem.
-John Tukey
©
#OC15Europe
The Best of Both WorldsOpenClinica’s foundations are
Strong data provenance, audit trails, privacy protections, and GCP compliance,
An open Source community that rapidly disseminates ideas and code, collaborates openly, welcomes new participants, and hold each other to rigorous quality standards.
The OpenClinica platform of the future will be Mobile-centric Real-time Patient and esource focused.
17
©
#OC15Europe
What is holding us back? In the race to ‘mHealth’, apps are not always what they
are cracked up to be:
However, obsolescence is nearly as bad:
18
A recent study in BMC Medicine found 67% of insulin dose calculator smartphone apps may contribute to incorrect dose recommendations
- mobihealthnews.com
“In mHealth… the technology may be obsolete before the trial is completed. Components of mHealth interventions may need to continuously improve during a trial. mHealth’s capabilities may change… existing research methods and may even enable development of new, more efficient designs
-Kumar et al. doi: 10.1016/j.amepre.2013.03.017
©
#OC15Europe
What is holding us back? New methods take time to adopt. Consider a pain scale:
19
Source: xkcd.com
©
#OC15Europe
What is holding us back? Regulatory burden - the ‘triple whammy’ of BYOD ePRO:
Instrument validation - across devices and screen sizes
Attributability - ensure it was the patient who completed it, in a way that’s at least as good as paper
eSource concerns – investigator control/retention of records
20
©
#OC15Europe 21
The Big Bet
Mobile technology can be a highly effective way to meaningfully engage participants in research:
Improving recruitment and retention Reducing in-person visits while getting better data Improving medication adherence Getting a better picture of AEs and side effects
©
#OC15Europe 22
The Big Bet
Engagement with patients using a mobile-centric, real-time approach can be a big part of solving our ‘which’ problem.
©
#OC15Europe 23
OpenClinica Toolkit
Going forward, OpenClinica will offer a richer, more diverse solution for meet the challenges of modern research
New mobile-friendly form engine
Dynamic, customizable dashboards
Easier to build reusable custom modules in a consistent manner
Better REST API
Visual design environment
Make sharing easy and seamless
©
#OC15Europe
Engaging as a Community Continue to participate and share as global & open
community
Ensure data provenance is the strongest part of our foundation
Build ties with other OSS health technology communities OpenRosa/JavaRosa Enketo tranSMART TraIT Sage
We can answer the ‘which’ questions!24
©
#OC15Europe
Thank You!
All our presenters, demonstrators, and workshop facilitators including keynote John Wilbanks
Rodica, Tia, and Rob, conference center and hotel staff, and all those who planned the event
All of our attendees!!!
25
Recommended